Saturday, 14 March 2009

Neurontin




In the US, Neurontin (gabapentin systemic) is a member of the drug class gamma-aminobutyric acid analogs and is used to treat Alcohol Withdrawal, Anxiety, Benign Essential Tremor, Bipolar Disorder, Burning Mouth Syndrome, Diabetic Nerve Damage, Epilepsy, Fibromyalgia, Hiccups, Hot Flashes, Hyperhidrosis, Insomnia, Migraine, Nausea/Vomiting - Chemotherapy Induced, Pain, Periodic Limb Movement Disorder, Peripheral Neuropathy, Persisting Pain - Shingles, Postmenopausal Symptoms, Pruritus, Reflex Sympathetic Dystrophy Syndrome, Restless Legs Syndrome, Trigeminal Neuralgia and Vulvodynia.

US matches:

  • Neurontin

  • Neurontin Capsules

  • Neurontin Solution

UK matches:

  • Neurontin Capsules and Tablets (SPC)

Ingredient matches for Neurontin



Gabapentin

Gabapentin is reported as an ingredient of Neurontin in the following countries:


  • Argentina

  • Australia

  • Austria

  • Bahrain

  • Belgium

  • Belize

  • Brazil

  • Canada

  • Costa Rica

  • Croatia (Hrvatska)

  • Cyprus

  • Czech Republic

  • Denmark

  • Ecuador

  • Egypt

  • El Salvador

  • Estonia

  • Finland

  • France

  • Germany

  • Greece

  • Guatemala

  • Honduras

  • Hong Kong

  • Hungary

  • Iceland

  • India

  • Indonesia

  • Ireland

  • Israel

  • Italy

  • Jordan

  • Kuwait

  • Latvia

  • Lebanon

  • Lithuania

  • Luxembourg

  • Malaysia

  • Malta

  • Mexico

  • Myanmar

  • Netherlands

  • New Zealand

  • Nicaragua

  • Norway

  • Oman

  • Panama

  • Philippines

  • Poland

  • Portugal

  • Romania

  • Russian Federation

  • Saudi Arabia

  • Serbia

  • Singapore

  • Slovakia

  • Slovenia

  • South Africa

  • Spain

  • Sweden

  • Switzerland

  • Taiwan

  • Thailand

  • Tunisia

  • Turkey

  • United Arab Emirates

  • United Kingdom

  • United States

  • Venezuela

  • Vietnam

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment